Comments on Funding:
Funding may consist in a grant or an investment.
Requested funds must range from $500,000 to $1,200,000. Exceptionally, CQDM may consider applications exceeding the maximum, if appropriate.
Applicants are responsible for raising matched funding for the project.
- be SMEs and public research institutions in Canada;
- conduct drug discovery research.
The applicant must:
submit a revised application, if required, including any additional information required and addressing comments, concerns and questions issued by the interested pharmaceutical members and/or CQDM’s Scientific Advisory Board.
Applicants must submit the CVs of all involved researchers.
Other Things to Note:
- CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy.
- Call for proposals are open year-round for Quantum Leap projects. Deadline to participate in the next selection round: November 17th, 2022